HETEROGENEOUS VASCULAR PATTERNS IN RENAL CELL CARCINOMAS

被引:11
作者
Ferician, Ovidiu [1 ]
Cimpean, Anca Maria [2 ]
Ceausu, Amalia Raluca [2 ]
Dema, Alis [3 ]
Raica, Marius [2 ]
Cumpanas, Alin [1 ]
机构
[1] Victor Babes Univ Med & Pharm Timisoara, Dept Urol, Timisoara, Romania
[2] Victor Babes Univ Med & Pharm Timisoara, Angiogenesis Res Ctr, Dept Microscop Morphol Histol, Timisoara, Romania
[3] Victor Babes Univ Med & Pharm Timisoara, Dept Pathol, Timisoara, Romania
关键词
renal cell carcinoma; CD34; SMAct; vascular pattern; ENDOTHELIAL GROWTH-FACTOR; MICROVESSEL DENSITY; TUMOR VASCULATURE; PROGNOSTIC-FACTOR; 1ST-LINE THERAPY; ENDOGLIN CD105; BLOOD-VESSELS; EXPRESSION; SUNITINIB; ANGIOGENESIS;
D O I
10.5114/PJP.2016.59477
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The present study proposes a classification of renal cancer tumor blood vessels according to their morphology and maturation grade. We identified four vascular patterns: reticular, diffuse, fasciculated and trabecular. The reticular pattern was present in 63% of cases, being characterized by the predominance of mature CD34+/SMAct+ tumor vessels, highly interconnected. For this pattern, 74% of cases had vascular invasion, and a significant correlation was observed between tumor grade and immature state of tumor vessels (p = 0.022). The diffuse pattern was observed in 23% of cases and was characterized by non-interconnected vessels predominantly of mature CD34+/SMAct+ type and vascular invasion in 64% of cases. Only 8% of cases, had a fasciculate model of vessels distribution, all of them being of mature type, located in the connective axis of papillary renal tumors. For this pattern vascular invasion was found in 50% of cases. In 6% of cases a trabecular pattern was observed and the lowest rate of vascular invasion was registered. We defined here four distinct vascular patterns in renal cell carcinomas showing a strong impact on vascular invasion. A complete morphological and molecular characterization of tumor vessels would be beneficial in elucidating the mechanisms that underlie the ineffectiveness of antiangiogenic/antitumor therapies.
引用
收藏
页码:46 / 53
页数:8
相关论文
共 23 条
[1]   Sunitinib still first-line therapy for metastatic renal cancer [J].
Bagcchi, Sanjeet .
LANCET ONCOLOGY, 2014, 15 (10) :E420-E420
[2]   Immuno-Expression of Endoglin and Smooth Muscle Actin in the Vessels of Brain Metastases. Is There a Rational for Anti-Angiogenic Therapy? [J].
Barresi, Valeria ;
Branca, Giovanni ;
Caffo, Maria ;
Caltabiano, Rosario ;
Ieni, Antonio ;
Vitarelli, Enrica ;
Lanzafame, Salvatore ;
Tuccari, Giovanni .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (04) :5663-5679
[3]   Effects of microbeam radiation therapy on normal and tumoral blood vessels [J].
Bouchet, Audrey ;
Serduc, Raphaeel ;
Laissue, Jean Albert ;
Djonov, Valentin .
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2015, 31 (06) :634-641
[4]   Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma [J].
Cao, Yun ;
Zhang, Zhi-Ling ;
Zhou, Ming ;
Elson, Paul ;
Rini, Brian ;
Aydin, Hakan ;
Feenstra, Kristin ;
Tan, Min-Han ;
Berghuis, Bree ;
Tabbey, Rebeka ;
Resau, James H. ;
Zhou, Fang-Jian ;
Teh, Bin Tean ;
Qian, Chao-Nan .
CANCER, 2013, 119 (02) :313-324
[5]  
Cheng SH, 2014, INT J CLIN EXP PATHO, V7, P5855
[6]   EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma [J].
Davis, I. D. ;
Long, A. ;
Yip, S. ;
Espinoza, D. ;
Thompson, J. F. ;
Kichenadasse, G. ;
Harrison, M. ;
Lowenthal, R. M. ;
Pavlakis, N. ;
Azad, A. ;
Kannourakis, G. ;
Steer, C. ;
Goldstein, D. ;
Shapiro, J. ;
Harvie, R. ;
Jovanovic, L. ;
Hudson, A. L. ;
Nelson, C. C. ;
Stockler, M. R. ;
Martin, A. .
ANNALS OF ONCOLOGY, 2015, 26 (06) :1118-1123
[7]   Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis [J].
Dubinski, William ;
Gabril, Manal ;
Iakovlev, Vladimir V. ;
Scorilas, Andreas ;
Youssef, Youssef M. ;
Faragalla, Hata ;
Kovacs, Kalman ;
Rotondo, Fabio ;
Metias, Shereen ;
Arsanious, Androu ;
Plotkin, Anna ;
Girgis, Andrew H. F. ;
Streutker, Catherine J. ;
Yousef, George M. .
HUMAN PATHOLOGY, 2012, 43 (07) :1037-1043
[8]   Quantifying Vascular Heterogeneity Using Microbubble Disruption-Replenishment Kinetics in Patients With Renal Cell Cancer [J].
Hudson, John M. ;
Williams, Ross ;
Karshafian, Raffi ;
Milot, Laurent ;
Atri, Mostafa ;
Burns, Peter N. ;
Bjarnason, Georg A. .
INVESTIGATIVE RADIOLOGY, 2014, 49 (02) :116-123
[9]   Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma [J].
Joshi, Shweta ;
Singh, Alok R. ;
Durden, Donald L. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) :595-608
[10]  
Okon K, 2008, POL J PATHOL, V59, P107